ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 223

$366K Total Retail Price of All Prescriptions

Rank: 108 out of 223

591 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 591 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 591 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,095 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
HYDROCODONE-ACETAMINOPHEN 499 458 S3 1 5
SIMVASTATIN 422 409 2 1
LEVOTHYROXINE SODIUM 412 391 3 2
LISINOPRIL 397 383 4 4
OMEPRAZOLE 338 298 5 3
AMLODIPINE BESYLATE 317 303 6 6
POTASSIUM CHLORIDE 282 276 7 12
CITALOPRAM HBR 255 234 8 16
ZOLPIDEM TARTRATE 243 243 9 8
FUROSEMIDE 224 224 10 9
METFORMIN HCL 218 195 11 7
ALENDRONATE SODIUM 199 192 12 19
WARFARIN SODIUM 195 194 13 11
HYDROCHLOROTHIAZIDE 188 180 14 13
GABAPENTIN 187 182 15 10
GLIMEPIRIDE 155 141 16 30
METOPROLOL TARTRATE 152 137 17 25
DONEPEZIL HCL 144 144 18 36
TRAZODONE HCL 138 119 19 22
PRAVASTATIN SODIUM 138 124 19 15
TRAMADOL HCL 118 103 21 18
ATENOLOL 117 106 22 32
FENOFIBRATE 116 103 23 38
SERTRALINE HCL 90 90 24 21
ALLOPURINOL 86 75 25 28
CARVEDILOL 72 72 26 23
METHADONE HCL 67 53 S2 27 114
ATORVASTATIN CALCIUM 66 55 28 17
METOPROLOL SUCCINATE 64 64 29 20
IBUPROFEN 63 50 30 46
LANTUS 63 49 30 34
LOSARTAN POTASSIUM 61 61 32 14
OXYBUTYNIN CHLORIDE 61 49 32 75
AZITHROMYCIN 58 57 34 44
KLOR-CON M20 58 58 34 67
NAMENDA 56 56 36 48
BENAZEPRIL HCL 56 56 36 57
PRAMIPEXOLE DIHYDROCHLORIDE 55 55 38 77
SPIRONOLACTONE 54 54 39 55
MIRTAZAPINE 54 48 39 94
FLUOXETINE HCL 53 52 41 24
PROAIR HFA 52 40 42 64
CYMBALTA 50 50 43 40
ROPINIROLE HCL 50 50 43 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.